Chemotherapy-Induced Arrhythmia - Underrecognized and Undertreated
- PMID: 34216562
- DOI: 10.1016/j.amjmed.2021.05.026
Chemotherapy-Induced Arrhythmia - Underrecognized and Undertreated
Abstract
Cancer is one of the leading causes of death worldwide. Chemotherapy-induced arrhythmia is a potential complication of treatment that confers increased morbidity and mortality. The relationship between chemotherapeutic agents and arrhythmias is poorly established. Atrial fibrillation, ventricular ectopic beats, and prolonged QTc are the most common arrhythmias suffered by cancer patients undergoing chemotherapy. The treatment of atrial fibrillation in cancer is complicated by complex drug-drug interactions and a lack of evidence guiding practice. Furthermore, the normal risk assessment scores utilized in the decision-making for anticoagulation in the normal population are not validated in the cancer population. Multiple agents are implicated in prolonging the QTc, and this can often have adverse consequences for both the patient and the treatment of their cancer. This can manifest as torsades de pointes and sudden cardiac death. It is advised that, during treatment, oncologists should have close liaison with cardio-oncologists to ensure optimum patient management.
Keywords: Arrhythmia; Atrial fibrillation; Cardio-oncology; Chemotherapy; Prolonged QTc.
Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.Curr Cardiol Rep. 2016 Jun;18(6):52. doi: 10.1007/s11886-016-0730-0. Curr Cardiol Rep. 2016. PMID: 27108362 Review.
-
Prolonged QTc interval in cancer therapeutic drug development: defining arrhythmic risk in malignancy.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):164-72. doi: 10.1016/j.pcad.2010.05.005. Prog Cardiovasc Dis. 2010. PMID: 20728704 Free PMC article. Review.
-
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms.Pharmacol Ther. 2018 Sep;189:89-103. doi: 10.1016/j.pharmthera.2018.04.009. Epub 2018 Apr 24. Pharmacol Ther. 2018. PMID: 29698683 Review.
-
QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.Target Oncol. 2015 Mar;10(1):27-43. doi: 10.1007/s11523-014-0325-x. Epub 2014 Jun 27. Target Oncol. 2015. PMID: 24970120 Review.
-
[QTc-prolonging drugs and the risk of sudden death].Medicina (Kaunas). 2007;43(4):347-53. Medicina (Kaunas). 2007. PMID: 17485963 Review. Lithuanian.
Cited by
-
How to properly evaluate cardiac vagal tone in oncology studies: a state-of-the-art review.J Natl Cancer Cent. 2024 Feb 13;4(1):36-46. doi: 10.1016/j.jncc.2024.02.002. eCollection 2024 Mar. J Natl Cancer Cent. 2024. PMID: 39036385 Free PMC article. Review.
-
Association of QTc Formula With the Clinical Management of Patients With Cancer.JAMA Oncol. 2022 Nov 1;8(11):1616-1623. doi: 10.1001/jamaoncol.2022.4194. JAMA Oncol. 2022. PMID: 36136321 Free PMC article.
-
Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies.Front Oncol. 2022 Jun 21;12:919279. doi: 10.3389/fonc.2022.919279. eCollection 2022. Front Oncol. 2022. PMID: 35800056 Free PMC article. Review.
-
The Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitors for Patients with Anticancer Therapy: A Meta-Analysis of Cohort Studies.Glob Heart. 2025 Jun 16;20(1):53. doi: 10.5334/gh.1440. eCollection 2025. Glob Heart. 2025. PMID: 40547873 Free PMC article.
-
Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms.J Cardiovasc Pharmacol. 2022 Oct 1;80(4):540-546. doi: 10.1097/FJC.0000000000001182. J Cardiovasc Pharmacol. 2022. PMID: 34803149 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
